Tag Archives: ACE

Top High Tech Stocks To Invest In Right Now

MicroVision, Inc. (NASDAQ:MVIS) has been quietly churning out high tech imaging and laser scanning technology for years. But MVIS stock began to soar last fall on news it was developing a lidar system for the automotive sector.

Source: temp-64GTX/Shutterstock.com

Between the start of December 2020 and Feb. 16 of this year, MVIS stock rocketed up by more than 920%. After a quick correction, it’s surged several times since, hitting a decade-long high close of $26.44 on April 26.

Top High Tech Stocks To Invest In Right Now: Grifols, S.A.(GRFS)

Grifols SA....More>>>

Top 5 Performing Stocks To Invest In Right Now

Robert Half International Inc. (RHI Quick QuoteRHI ) is a staffing and risk consulting services provider that has performed brilliantly over the past year and has the potential to sustain the momentum in the near term. Consequently, if you haven’t taken advantage of the share-price appreciation yet, it’s time you add the stock to your portfolio.

What Makes Robert Half an Attractive Pick?

An Outperformer: A glimpse of the company’s price trend reveals that the stock has had an impressive run on the bourse over the past year. Shares of Robert Half have....More>>>

Top 5 Low Price Stocks To Own Right Now

No doubt, a strong portfolio typically includes stocks with robust fundamentals and solid track records. In a bull market, these investments provide healthy returns and protect against capital erosion. However, we should not overlook the benefits of owning penny stocks, either. The get-rich-quick angle with these picks is a real possibility. That’s why they continue to garner investor interest.

That said, penny stocks can also be a double-edged sword. Naturally, everyone is attracted to the low price tag. But it’s extremely important to understand which stocks are trading....More>>>

Top 5 Medical Stocks To Invest In Right Now

What happened

Shares of Insys Therapeutics (NASDAQ:INSY) rose 11% in June, according to data provided by S&P Global Market Intelligence. While the biotech is most famous for its opioid painkiller Subsys as well as Syndros, which is based on a compound in marijuana, it was clinical trial data from a new product that has investors excited.

So what

In the clinical trial, Insys’ epinephrine nasal spray had similar bioavailability as intramuscular injection with Mylan’s (NASDAQ:MYL) EpiPen, which also delivers epinephrine to treat anaphylaxis after exposure....More>>>

Top Stocks To Invest In 2019

Brokerages expect Ascendis Pharma A/S (NASDAQ:ASND) to post sales of $160,000.00 for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for Ascendis Pharma A/S’s earnings. The lowest sales estimate is $30,000.00 and the highest is $230,000.00. Ascendis Pharma A/S reported sales of $490,000.00 during the same quarter last year, which would suggest a negative year-over-year growth rate of 67.3%. The firm is expected to report its next quarterly earnings results on Friday, August 17th.

According to Zacks, analysts expect that....More>>>